ISSN: 2159-8274

Journal Home

Journal Guideline

Cancer Discovery Q1 Unclaimed

American Association for Cancer Research Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Discovery is a journal indexed in SJR in Oncology with an H index of 138. It has a price of 4524 €. It has an SJR impact factor of 7,513 and it has a best quartile of Q1.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Oncology (Q1)

Price

4524 €

Gold OA

-

Green OA

2262 €

Non OA

Metrics

7,513

SJR Impact factor

138

H Index

500

Total Docs (Last Year)

1120

Total Docs (3 years)

5849

Total Refs

7605

Total Cites (3 years)

707

Citable Docs (3 years)

10,33

Cites/Doc (2 years)

11,7

Ref/Doc

Aims and Scope

Other journals with similar parameters

Nature Reviews Clinical Oncology Q1
CA - A Cancer Journal for Clinicians Q1
JAMA oncology Q1
Journal of the National Cancer Institute Q1
Clinical Cancer Research Q1

Best articles

A Little pRB Can Lead to Big Problems

Adenoid Cystic Carcinoma Can Be Driven by MYB or MYBL1 Rearrangements: New Insights into MYB and Tumor Biology

BluepRINT for Moderate-to-Low Penetrance Cancer Susceptibility Genes Needed: Breast Cancer and Beyond

Collateral Genome Instability by DNA Damage in Mitosis

Dual MAPK/CDK Targeting in Melanoma: New Approaches, New Challenges

Escaping Out of the Brain

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study

Gain-of-function genetic alterations of G9a drive oncogenesis

Haploinsufficiency of an RB-E2F1-Condensin II Complex Leads to Aberrant Replication and Aneuploidy

Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes

Insights into Epigenetic Remodeling in VHL-Deficient Clear Cell Renal Cell Carcinoma

Insights into the Mechanism of Organ-Specific Cancer Metastasis

SHOW MORE ARTICLES

Large-Scale Drug Screens Support Precision Medicine

Lifting Up the HAT: Synthetic Lethal Screening Reveals a Novel Vulnerability at the CBP-p300 Axis

Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical Models

Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells

Predicting Cancer Drug Response: Advancing the DREAM

Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation

Social Interactomes for Enabling Research Communities

SPSB1 May Have MET Its Match during Breast Cancer Recurrence

Targeting Apoptosis: A New Paradigm for the Treatment of Estrogen Receptor-Positive Breast Cancer

Tumor microenvironment is critical for the maintenance of cellular states found in primary glioblastomas.

Tumor-Promoting and -Suppressive Roles of Autophagy in the Same Mouse Model of BrafV600E-Driven Lung Cancer

YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.